Featured
August 14, 2026
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
As an extension of the ASAP CRN Impact Report 2020–2024, this report highlights the cross-cutting scientific themes, field-enabling resources, infrastructure efforts, and key discoveries accelerating breakthroughs in PD research across our Collaborative Research Network (CRN).
View Story
Parkinson’s News Today reports that the ASAP has awarded a $9 million grant to scientists from Cedars-Sinai, to investigate how exposure to specific pesticides and air pollutants interacts with genetic vulnerabilities to trigger the development of the disease.
View Story
Alzforum dives into the global scale of a $261 million investment by ASAP in partnership with The Michael J. Fox Foundation, which expands the Collaborative Research Network (CRN), to transform Parkinson's research by generating standardized tools and investigating the root causes of the disease.
View Story
Parkinson’s News Today reports that ASAP and The Michael J. Fox Foundation are investing $261 million to expand the Collaborative Research Network (CRN) to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies.
View Story
In this edition of the ASAP Research Round-Up, ASAP presents Q1 2026 highlights from across its portfolio, showcasing efforts to advance Parkinson’s discovery, facilitate the rapid global exchange of ideas, broaden open-science accessibility, and support the next generation of Parkinson’s researchers.
Read More
We are proud to share how we impacted the Parkinson’s disease research field in 2025. Read our report to see how the infrastructure and processes we established are changing the way science is done and are generating significant momentum.
Read More
In the third edition of the ASAP Research Round-Up, we share highlights from the past quarter across the ASAP portfolio that funnel new ideas into Parkinson’s disease (PD) research, facilitate the exchange of scientific ideas, expand access to resources for PD research, and support the next generation of Parkinson’s disease researchers.
Read More
This news story reports on a new, advanced imaging method that allowed CRN Team Wood to see and study the tiny, toxic alpha-synuclein oligomers (protein clumps) in the brain, creating a new opportunity for earlier diagnosis and better drug treatments.
View Story
In this second edition of the ASAP Research Round-Up, ASAP shares advancements in Q2 2025 across the ASAP portfolio that fill critical knowledge gaps, promote rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
Read More
